ImmunoPrecise Antibodies Ltd

TQB

Company Profile

  • Business description

    ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

  • Contact

    Industrious 823 Congress Avenue
    Suite 300
    AustinTX78701
    USA

    https://www.ipatherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 April 2026

    Employees

    101

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,824.102.30-0.03%
CAC 407,723.4727.200.35%
DAX 4024,073.67286.221.20%
Dow JONES (US)44,406.36422.17-0.94%
FTSE 1008,806.5316.38-0.19%
HKSE23,977.7489.910.38%
NASDAQ20,412.52188.59-0.92%
Nikkei 22539,673.3185.630.22%
NZX 50 Index12,745.9019.05-0.15%
S&P 5006,229.9849.37-0.79%
S&P/ASX 2008,584.504.80-0.06%
SSE Composite Index3,479.456.320.18%

Market Movers